Claes Tomas Post

Direktor/Vorstandsmitglied bei

Oblique Therapeutics AB

76 Jahre

90 Beziehungen

Health Technology

Finance

Consumer Services

Profil

Claes Tomas Post is currently a Director at Oblique Therapeutics AB and STOAF III Venture Partners AB. He is also a Director at Apotekarsocieteten since 2014 and a General Partner at Stockholms Affärsänglar Management AB since 2017.
In the past, he served as the Chief Executive Officer at Melacure Therapeutics AB from 2003 to 2005, and as the Chief Executive Officer at Karolinska Institutet Innovations AB from 2008 to 2011.
He was also a Venture Partner at HealthCap AB and Nordic Biotech Advisors ApS.
Dr. Post holds a graduate degree from the University of Uppsala and a doctorate degree from the University of Linköping.

Aktive Positionen von Claes Tomas Post

Unternehmen	Position	Beginn
Oblique Therapeutics AB Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties	Direktor/Vorstandsmitglied	-
STOAF III Venture Partners AB	Direktor/Vorstandsmitglied	-
University of Uppsala University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	01.09.1988
Stockholms Affärsänglar Management AB Stockholms Affärsänglar Management AB Investment ManagersFinance STOAF invests in companies located in the Nordic region primarily in Sweden. The firm targets companies operating in the fields of life sciences, advanced industrial technologies, advanced ICT and sustainable energy technologies. It provides financing for early stage capital requirements and offers co-investment rights to limited partners.	Private Equity Investor	01.01.2017
Apotekarsocieteten	Direktor/Vorstandsmitglied	01.01.2014

Alle aktiven Positionen von Claes Tomas Post

Ehemalige bekannte Positionen von Claes Tomas Post

Unternehmen	Position	Ende
XINTELA AB	Direktor/Vorstandsmitglied	01.03.2020
Gradientech AB Gradientech AB Medical SpecialtiesHealth Technology Provides ultra-rapid antibiotic susceptibility testing services	Direktor/Vorstandsmitglied	01.03.2018
University of Linköping University of Linköping Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	01.03.2017
Almi Invest AB Almi Invest AB Investment ManagersFinance Almi invests in companies located in Sweden. The firm targets companies operating in the fields of tech & deeptech, industry, life science and sustainability sectors. It provides financing for pre-seed, seed and growth transactions with an investment size of SEK 1 - 10 million. The firm takes seat on board of directors and makes co-investments.	Chief Investment Officer	30.09.2015
░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ ░░	░░░░░░░░░░░░░░░░░░░░░	░░░░░░░░░░

Sehen Sie sich die Erfahrung von Claes Tomas Post im Detail an

Ausbildung von Claes Tomas Post

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Claes Tomas Post im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	30
HealthCap AB HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements.	Finance
Pharmacia AB Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern	Health Technology
University of Uppsala University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Nordic Biotech Advisors ApS Nordic Biotech Advisors ApS Investment ManagersFinance NB Capital is an active manager which provides financing for pre-seed, seed, later, and growth-stage capital requirements, and invests in both public and private companies. The firm invests in young and established companies operating in the health technology sector, and industries such as biotechnology and pharmaceuticals. NB Capital invests in companies located in Denmark, Northern Europe, and North America, and looks to take minority stake positions in its investments, as well as a seat on the board.	Finance
Melacure Therapeutics AB Melacure Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	Health Technology
University of Linköping University of Linköping Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Rose Pharma A/S Rose Pharma A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products for treatment of pain in connection with irritable bowel syndrome	Health Technology
Astra LLC Astra LLC Wholesale DistributorsDistribution Services Manufactures refrigeration systems	Distribution Services
Astra Draco AB
AroCell AB AroCell AB Medical SpecialtiesHealth Technology Provides cancer therapy	Health Technology
KDev Exploratory AB KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services Provides drug discovery solutions	Commercial Services
Denator AB Denator AB Medical SpecialtiesHealth Technology Provides instruments and consumables that stabilize biological samples	Health Technology
Aprea Therapeutics AB Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds	Health Technology
Pharmacia Upjohn
Karolinska Institutet Innovations AB Karolinska Institutet Innovations AB Financial ConglomeratesFinance Operates, develops, and finances projects in-house and utilizes research to improve human health	Finance
Pharmacia Italia Spa
Almi Invest AB Almi Invest AB Investment ManagersFinance Almi invests in companies located in Sweden. The firm targets companies operating in the fields of tech & deeptech, industry, life science and sustainability sectors. It provides financing for pre-seed, seed and growth transactions with an investment size of SEK 1 - 10 million. The firm takes seat on board of directors and makes co-investments.	Finance
AddBIO AB AddBIO AB BiotechnologyHealth Technology Provides bone implant technology solutions	Health Technology
Sprint Bioscience AB Sprint Bioscience AB Pharmaceuticals: MajorHealth Technology Develops medicines in the field of cancer and metabolism	Health Technology
Stockholms Affärsänglar Management AB Stockholms Affärsänglar Management AB Investment ManagersFinance STOAF invests in companies located in the Nordic region primarily in Sweden. The firm targets companies operating in the fields of life sciences, advanced industrial technologies, advanced ICT and sustainable energy technologies. It provides financing for early stage capital requirements and offers co-investment rights to limited partners.	Finance
Xintela AB Xintela AB BiotechnologyHealth Technology Provides treatment and medicine for articular cartilage injuries and diseases	Health Technology
Gradientech AB Gradientech AB Medical SpecialtiesHealth Technology Provides ultra-rapid antibiotic susceptibility testing services	Health Technology
Sigrid Therapeutics AB Sigrid Therapeutics AB Pharmaceuticals: OtherHealth Technology Manufactures and sells dietary supplement products for blood sugar & weight management, glucose stabilizer and foods	Health Technology
Genagon Therapeutics AB Genagon Therapeutics AB BiotechnologyHealth Technology Provides scientific and technical research and development services	Health Technology
Dicot Pharma AB Dicot Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs to treat erectile failure	Health Technology
Astra Pain Control AB
Oblique Therapeutics AB Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties	Health Technology
Ct Post AB Ct Post AB Miscellaneous Commercial ServicesCommercial Services Provides management consulting services	Commercial Services
STOAF III Venture Partners AB
Apotekarsocieteten